COVID research cuts target work on antivirals and vaccines to prevent future pandemicsnews2025-03-28T20:06:46+00:00March 28th, 2025|Endpoints News|
Bluebird gets new M&A bid, seeking to top private equity offernews2025-03-28T19:51:41+00:00March 28th, 2025|Endpoints News|
Novartis’ radiopharma drug Pluvicto gets an expanded labelnews2025-03-28T18:45:27+00:00March 28th, 2025|Endpoints News|
FDA approves Sanofi’s RNAi drug for hemophilia A and Bnews2025-03-28T18:45:21+00:00March 28th, 2025|Endpoints News|
BioNTech details promising mid-stage data for its PD-L1xVEGF in aggressive lung cancernews2025-03-28T12:00:53+00:00March 28th, 2025|Endpoints News|
Merck KGaA pays Abbisko $85M for full commercial rights to benign tumor drugnews2025-03-28T10:53:30+00:00March 28th, 2025|Endpoints News|
Merck details injectable Keytruda data as it awaits FDA decisionnews2025-03-27T18:31:35+00:00March 27th, 2025|Endpoints News|
Equillium says graft-versus-host drug fails Phase 3, stock divesnews2025-03-27T14:56:11+00:00March 27th, 2025|Endpoints News|
Candel to focus on non-squamous lung cancer following new survival datanews2025-03-27T11:09:19+00:00March 27th, 2025|Endpoints News|
